Clinical Trial Update: Study of Oral AEE788 in Adults With Advanced Cancer [Phase 1]

View source ↗

Summary

This clinical trial update covers a Phase 1 study of the oral investigational drug AEE788 in adults with advanced cancer, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AEE788

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cancer | Phase 1 | Status: COMPLETED